openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News

Sponsored

Pascal Soriot — news, coverage & facts — IJR

|NewsJournalsPersonPascal Soriot

Pascal Soriot

Person

Pascal Soriot

3 members

What's driving coverage of Pascal Soriot right now?

3 memberscoverage spread: L25/C25/R50

Comments

Ask this entity anything:

Free account · your comment posts right after signup

Photo: Arne Müseler / Wikimedia Commons (CC BY-SA 3.0 de)
Business
AstraZeneca Posts Q2 Beat, Reaffirms 2026 Outlook
AstraZeneca beat second-quarter profit expectations and reaffirmed its 2026 outlook despite concerns about future growth after a trial setback, as investors await further details on its earnings trajectory. Analysts are mixed but broadly positive, with several buy ratings and a focus on the upcoming Q2 results and oncology-driven revenue, amid a broader market backdrop of cautious trading ahead of earnings.
43 sources

Facts from Wikidata (CC0).

Overview

Sir Pascal Claude Roland Soriot is a French-born Australian businessman and chief executive of the British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca.

Sir Pascal Claude Roland Soriot is a French-born Australian businessman and chief executive of the British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca.

Pascal Soriot across IJR

Studio characters

Pascal SoriotAsk the French businessman everything the interviews skip.

Ask Genius about Pascal Soriot Create in Studio Build a game Watch videos